News | February 03, 2022
Caplin Point Q3FY22 PAT at Rs 74.95 cr.
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health
The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists
Subscribe To Our Newsletter & Stay Updated
